4.6 Article

Serum Cystatin C Predicts Stroke Clinical Outcomes at 1 Year Independent of Renal Function

Journal

FRONTIERS IN NEUROLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fneur.2021.676872

Keywords

cystatin C; renal function; biomarker; ischemic stroke; clinical outcomes

Funding

  1. National Key R&D program of China [2018YFC1312903]
  2. National Science and Technology Major Project [2017ZX09304018]
  3. Beijing Municipal Science & Technology Commission [D171100003017002, Z181100001818001]

Ask authors/readers for more resources

This study found a U-shaped correlation between serum CysC levels and 1-year stroke clinical outcomes in patients with acute ischemic stroke, suggesting that CysC may not only be a marker of renal function but also play a role in predicting cardiovascular events.
Objective: Serum cystatin C (CysC) is a sensitive marker of renal function to predict cardiovascular diseases. We aimed to investigate the predictive value of CysC for clinical outcomes independent of renal function in patients with acute ischemic stroke (AIS). Methods: We measured serum CysC levels in 10,256 AIS patients from Third China National Stroke Registry (CNSR-III). The primary outcome was a combination of all-cause mortality and major disability (modified Rankin scale score, 3-6). Secondary outcomes included stroke recurrence and combined vascular events at 1 year. Outcomes were analyzed using logistic regression and Cox proportional hazards models, respectively. Results: The median CysC of included patients was 0.95 mg/l (interquartile range, 0.83- 1.10 mg/l). A U-shaped association was observed between CysC and primary outcome (all-cause mortality or major disability) [quartile (Q)1 vs. Q2: adjusted odds ratio (aOR) 1.29, 95% CI 1.06-1.58, p = 0.012; Q3 vs. Q2: aOR 1.12, 95% CI 0.93-1.35, p = 0.242; Q4 vs. Q2: aOR 1.35, 95% CI 1.10-1.65, p = 0.004]. A similar trend also existed in preserved renal function patients. Adding CysC to a model containing conventional risk factors improved the model performance with integrated discrimination improvement (IDI) of 0.13% (p = 0.016) and net reclassification index (NRI) of 13.10% (p < 0.001) for primary outcome. No significant association was observed for stroke recurrence or combined vascular event rate in different CysC quartiles. Conclusions: CysC showed a U-shaped correlation with 1-year stroke clinical outcome, suggesting that serum CysC may not only be a simple candidate marker of renal function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available